asbestos lawyers - Worthington & Caron, PC

Over $2.5 billion

obtained for mesothelioma patients & families

Mesothelioma Empowerment

Latest News Articles By Category

Feb 24 2022

$5M Awarded to Retired Contractor Exposed to Asbestos from Drywall Products

The asbestos attorneys of Worthington & Caron, P.C. are pleased to report that on February 16, 2022, a Santa Monica Jury awarded $5 million to our clients in a case entitled Brooks vs. Kaiser Gypsum Company, Inc., et al. (LASC Case No. ...

Continue Reading...
Nov 1 2016

69 Year-Old Carpenter and Contractor Has "Lived a Good Life"

In the summer of 2015, Roy first began experiencing pain on his right side. He of course ignored the pain because if you knew Roy, you would understand what a tough hombre is he! Roy has been working construction since he was 12 years old. He was ...

Continue Reading...
Oct 31 2016

Jury Awards $18M to Retired City Government Official Who Contracted Mesothelioma from Asbestos-Contaminated Talcum Powder

The Worthington Caron Law Firm is pleased to report that on October 19, 2016, a Los Angeles jury awarded $18,070,000 to our clients in a case entitled Depoian v. American International Industries, Inc. et al. (Los Angeles Superior Court Case Number ...

Continue Reading...
Oct 31 2016

Jury Awards $7M to Retired Banker Exposed to Asbestos Renovating Homes

The Worthington Caron Law Firm is pleased to report that on October 24, 2016 a Los Angeles jury awarded $7,042,300 to our clients in Los Angeles Superior Court Case Number BC604809. The plaintiff was diagnosed with pleural mesothelioma, a cancer ...

Continue Reading...
May 9 2022

BAP1 Genetic Mutation in Mesothelioma Warrants New Treatment Approaches

The University of Hawaii Cancer Center has published novel research on the BAP1 genetic mutation found in an estimated 10% of patients with mesothelioma with the goal of better understanding the unique traits of carriers of the mutation. Michele ...

Continue Reading...
May 26 2021

The Sounds of Summer with Voices of Classic Soul!

What : Soul Music. A kind of music incorporating elements of rhythm and blues and gospel music. Characterized by an emphasis on vocals and an impassioned improvisatory delivery. Who : Voices of Classic Soul Music. A group made up of Joe Coleman, Joe ...

Continue Reading...
Mar 8 2021

"We Got Married in a Fever!" The WALKING PHOENIXES: Virtual Johnny Cash Tribute Concert

Wow, if you missed the Walking Phoenixes Virtual Concert Birthday Bash of Johnny Cash & June Carter on February 26th, you missed something special. It was if they were playing right in your living room, which they were! You can watch a clip of ...

Continue Reading...
Nov 16 2020

The Pacific Mesothelioma Center's 9th Annual Walk/hike for Mesothelioma Raises Record High of $527,000

Yes, that’s correct! Even during these difficult times, the Pacific Mesothelioma Center (PMC) raised a over $527,000 for mesothelioma research – a record! Worthington & Caron, P.C. again served as the lead sponsor of that event and ...

Continue Reading...
May 20 2022

Tazemetostat Proves Effective in Treatment of Mesothelioma with BAP1 Mutation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...

Continue Reading...
May 19 2022

Johnson & Johnson's Bankruptcy Plan to be Reviewed by Appellate Court

A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
May 12 2022

Mark Your Calendars! Time to Register for Pacific Mesothelioma Center's 11th Annual 5k Walk/Hike for Mesothelioma!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...

Continue Reading...
May 20 2022

Tazemetostat Proves Effective in Treatment of Mesothelioma with BAP1 Mutation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...

Continue Reading...
May 19 2022

Johnson & Johnson's Bankruptcy Plan to be Reviewed by Appellate Court

A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
May 12 2022

Mark Your Calendars! Time to Register for Pacific Mesothelioma Center's 11th Annual 5k Walk/Hike for Mesothelioma!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...

Continue Reading...
May 20 2022

Tazemetostat Proves Effective in Treatment of Mesothelioma with BAP1 Mutation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...

Continue Reading...
May 19 2022

Johnson & Johnson's Bankruptcy Plan to be Reviewed by Appellate Court

A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
May 12 2022

Mark Your Calendars! Time to Register for Pacific Mesothelioma Center's 11th Annual 5k Walk/Hike for Mesothelioma!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...

Continue Reading...
May 20 2022

Tazemetostat Proves Effective in Treatment of Mesothelioma with BAP1 Mutation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...

Continue Reading...
May 19 2022

Johnson & Johnson's Bankruptcy Plan to be Reviewed by Appellate Court

A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
May 12 2022

Mark Your Calendars! Time to Register for Pacific Mesothelioma Center's 11th Annual 5k Walk/Hike for Mesothelioma!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...

Continue Reading...
May 20 2022

Tazemetostat Proves Effective in Treatment of Mesothelioma with BAP1 Mutation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...

Continue Reading...
May 19 2022

Johnson & Johnson's Bankruptcy Plan to be Reviewed by Appellate Court

A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
May 12 2022

Mark Your Calendars! Time to Register for Pacific Mesothelioma Center's 11th Annual 5k Walk/Hike for Mesothelioma!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...

Continue Reading...
Mar 23 2015

New Asbestos Bills Before Congress, but will Meaningful Legislature Finally be Passed?

A new bill has been introduced to congress this week which would require the Environmental Protection Agency (EPA) to re -consider a ban on asbestos, and many other toxic chemicals that have been found to cause cancer, developmental disorders, ...

Continue Reading...
Feb 13 2015

The Truth Behind the FACT Act

Robert Weissman, President of Public Citizen, a non-profit, consumer rights advocacy group and think tank based in D.C., shared some facts regarding the so-called “Furthering Asbestos Claims Transparency Act” (FACT Act) in an article ...

Continue Reading...
Nov 14 2013

Asbestos Industry-Backed FACT Act Passed by House GOP's-But Not Likely to Go Any Further

US News reports that on Wednesday, November 13, 2013 the House approved House Resolution 982, the Furthering Asbestos Claim Transparency Act (FACT Act) in a vote 221-199. The FACT Act is part of a national campaign being led by the American ...

Continue Reading...
Aug 9 2013

The Chemical Safety Improvement Act of 2013 - Yet Another Obstacle to Banning Asbestos in the U.S

The Chemical Safety Improvement Act of 2013 (S. 1009) (CSIA) is a bill currently before congress. The legislation is designed to reform the Toxic Substances Control Act (TSCA) of 1976. Many public health advocates who support TSCA reform do not ...

Continue Reading...
Dec 16 2016

Study Shows That New Treatment Method May Dramatically Increase the Lifespan of Patients with Malignant Pleural Mesothelioma

A study conducted by a team of researchers from the University of Maryland Medical System, the University of Maryland School of Medicine, the Penn-Presbyterian Medical Center, the University of Pennsylvania and the Hospital of the University of ...

Continue Reading...
Jun 16 2016

Does Surgery for Mesothelioma Improve Quality of Life?

When it comes to mesothelioma, surgery could be a helpful option to prolong the life of the patient. However, there are a number of patients who may undergo surgery because they believe it will impact their quality of life. This is an interesting ...

Continue Reading...
May 20 2022

Tazemetostat Proves Effective in Treatment of Mesothelioma with BAP1 Mutation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...

Continue Reading...
May 19 2022

Johnson & Johnson's Bankruptcy Plan to be Reviewed by Appellate Court

A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
May 12 2022

Mark Your Calendars! Time to Register for Pacific Mesothelioma Center's 11th Annual 5k Walk/Hike for Mesothelioma!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...

Continue Reading...
May 19 2022

Johnson & Johnson's Bankruptcy Plan to be Reviewed by Appellate Court

A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
May 12 2022

Mark Your Calendars! Time to Register for Pacific Mesothelioma Center's 11th Annual 5k Walk/Hike for Mesothelioma!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...

Continue Reading...
May 9 2022

BAP1 Genetic Mutation in Mesothelioma Warrants New Treatment Approaches

The University of Hawaii Cancer Center has published novel research on the BAP1 genetic mutation found in an estimated 10% of patients with mesothelioma with the goal of better understanding the unique traits of carriers of the mutation. Michele ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
May 12 2022

Mark Your Calendars! Time to Register for Pacific Mesothelioma Center's 11th Annual 5k Walk/Hike for Mesothelioma!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...

Continue Reading...
May 9 2022

BAP1 Genetic Mutation in Mesothelioma Warrants New Treatment Approaches

The University of Hawaii Cancer Center has published novel research on the BAP1 genetic mutation found in an estimated 10% of patients with mesothelioma with the goal of better understanding the unique traits of carriers of the mutation. Michele ...

Continue Reading...
May 6 2022

Hyperthermic Intrathoracic Chemotherapy is Associated with Longer Survival in Mesothelioma Patients

Researchers in the U.K. have published a systemic review analyzing 598 pleural mesothelioma patients that have undergone hyperthermic intrathoracic chemotherapy (“HITHOC”) immediately following surgery in the hopes of eradicating ...

Continue Reading...
Apr 28 2022

Johnson & Johnson Shareholders to Vote to End Sales of Talc-Based Baby Powder Worldwide

Johnson & Johnson is being forced into a shareholder vote today, Thursday, April 28, at its 2022 Annual Shareholder meeting to end all sales of its talc-based baby powder globally. The company ceased sales of the product in the US and Canada in ...

Continue Reading...
Feb 24 2022

$5M Awarded to Retired Contractor Exposed to Asbestos from Drywall Products

The asbestos attorneys of Worthington & Caron, P.C. are pleased to report that on February 16, 2022, a Santa Monica Jury awarded $5 million to our clients in a case entitled Brooks vs. Kaiser Gypsum Company, Inc., et al. (LASC Case No. ...

Continue Reading...
Apr 28 2021

Los Angeles Jury Awards $4.8 Million in Mesothelioma Case Against Old Spice Talc Supplier Whittaker Clark & Daniels

The Worthington & Caron Law Firm is pleased to report that on April 15 and 16, 2021, a Los Angeles jury returned verdicts totaling $4.8 million in favor of our client Willie McNeal Jr. in a case entitled McNeal Jr. vs. Whittaker, Clark & ...

Continue Reading...
Oct 31 2016

Jury Awards $18M to Retired City Government Official Who Contracted Mesothelioma from Asbestos-Contaminated Talcum Powder

The Worthington Caron Law Firm is pleased to report that on October 19, 2016, a Los Angeles jury awarded $18,070,000 to our clients in a case entitled Depoian v. American International Industries, Inc. et al. (Los Angeles Superior Court Case Number ...

Continue Reading...
Aug 13 2020

Matching Pledge Offered for 9th Annual Walk/Hike for Mesothelioma

The Pacific Mesothelioma Center (PMC), a division of the Pacific Heart, Lung & Blood Institute (PHLBI), is pleased to announce a matching pledge from an anonymous donor who owes his life to and is grateful and thankful to Dr. Robert Cameron. The ...

Continue Reading...
Oct 7 2019

Join Us for the Pacific Meso Center's 8th Annual Walk for Mesothelioma on October 26, 2019

The Pacific Meso Center’s 8 th Annual Walk for Mesothelioma is only a few weeks away! Worthington & Caron, P.C. is proud to serve as lead sponsor for this fun and important fundraising event, as we have done every year since its inception ...

Continue Reading...
Mar 20 2019

Register Now for the Greatest Escape Motorcycle Ride on April 6, 2019!

It’s time to “Get your motor running…Head out on the Highway” for the 2019 Greatest Escape Motorcycle Ride!! The ride, which raises funds for mesothelioma research conducted by the Pacific Mesothelioma Center in Los Angeles, ...

Continue Reading...
Mar 11 2019

The Pacific Meso Center Issued a Patent for Mesenchymal Stem Cell Research

The Pacific Mesothelioma Center (PMC) announced the issuance of a U.S. patent for their mesenchymal stem research program. The patent’s inventors Dr. Raymond Wong and Dr. Robert B. Cameron, Scientific Advisor at PMC, Director of the UCLA ...

Continue Reading...
Sep 26 2018

Join Us for the 8th International Symposium on Malignant Pleural Mesothelioma Saturday, September 29th at the UCLA Luskin Center

Worthington & Caron, PC is proud to be lead sponsor of the The 8th International Mesothelioma Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, where International Experts from around the world will meet to discuss the ...

Continue Reading...
Apr 28 2015

It's Not Too Late! Register Today for the 5th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma!

It’s not too late to register! Join us this weekend as some of the world’s leading mesothelioma experts and advocates highlight the most promising medical advances in mesothelioma treatment and cutting-edge new research. The 5 th ...

Continue Reading...
Apr 1 2015

Early Bird Special! Register Now for the 5th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma!

Worthington & Caron is pleased to announce that it will once again be sponsoring the 5 th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma. The 5 th Annual Symposium will once again be held at the Le ...

Continue Reading...
Jun 9 2014

Dr. Robert Cameron Chairs International Panel of Medical Specialists at 4th Annual Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma

The Pacific Meso Center, in conjunction with The Office of Continuing Medical Education of the David Geffen School of Medicine at UCLA, held the 4th International Symposium on Lung-SparingTherapies for Malignant Pleural Mesothelioma on June 7, 2014 ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
Apr 28 2022

Johnson & Johnson Shareholders to Vote to End Sales of Talc-Based Baby Powder Worldwide

Johnson & Johnson is being forced into a shareholder vote today, Thursday, April 28, at its 2022 Annual Shareholder meeting to end all sales of its talc-based baby powder globally. The company ceased sales of the product in the US and Canada in ...

Continue Reading...
Mar 16 2022

Johnson & Johnson's Controversial Prison Experiments Revealed

Unsealed documents from more than 50 years ago, reveal that Johnson & Johnson funded experiments on prison inmates to examine the effects of talc. Bloomberg News reports that J&J’s involvement in these controversial talc studies was not ...

Continue Reading...
Feb 21 2022

Senator Durbin Blasts Johnson & Johnson's Bankruptcy Plan

Speaking from the U.S. Senate floor on February 15, Sen. Dick Durbin condemned Johnson & Johnson’s controversial bankruptcy strategy, which he labeled “shameful and indefensible”, to limit their massive legal liability to ...

Continue Reading...
May 6 2022

Hyperthermic Intrathoracic Chemotherapy is Associated with Longer Survival in Mesothelioma Patients

Researchers in the U.K. have published a systemic review analyzing 598 pleural mesothelioma patients that have undergone hyperthermic intrathoracic chemotherapy (“HITHOC”) immediately following surgery in the hopes of eradicating ...

Continue Reading...
Feb 7 2017

A Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With Relapsed or Refractory Malignant Mesothelioma With BAP1 Loss of Function

Tazemetostat is an investigational drug that kills cancer cells by stopping a gene called EZH2 from working. EZH2 affects how two other genes, INI1 and SMARCA4 work in cells. In early clinical development, tazemetostat has demonstrated clinical ...

Continue Reading...
Dec 16 2016

Study Shows That New Treatment Method May Dramatically Increase the Lifespan of Patients with Malignant Pleural Mesothelioma

A study conducted by a team of researchers from the University of Maryland Medical System, the University of Maryland School of Medicine, the Penn-Presbyterian Medical Center, the University of Pennsylvania and the Hospital of the University of ...

Continue Reading...
Nov 15 2016

An Aspirin a Day May Keep Mesothelioma Away

A recent study reveals that taking an aspirin every day may be effective in preventing or delaying the onset of mesothelioma in persons exposed to asbestos. The Facts Mesothelioma is an aggressive cancer caused by exposure to asbestos affecting over ...

Continue Reading...
Feb 24 2022

$5M Awarded to Retired Contractor Exposed to Asbestos from Drywall Products

The asbestos attorneys of Worthington & Caron, P.C. are pleased to report that on February 16, 2022, a Santa Monica Jury awarded $5 million to our clients in a case entitled Brooks vs. Kaiser Gypsum Company, Inc., et al. (LASC Case No. ...

Continue Reading...
Oct 31 2016

Jury Awards $18M to Retired City Government Official Who Contracted Mesothelioma from Asbestos-Contaminated Talcum Powder

The Worthington Caron Law Firm is pleased to report that on October 19, 2016, a Los Angeles jury awarded $18,070,000 to our clients in a case entitled Depoian v. American International Industries, Inc. et al. (Los Angeles Superior Court Case Number ...

Continue Reading...
Feb 12 2016

$5,776,500.00 for Family of Mesothelioma Patient

$5,776,500.00 for the family of a 60 year old mesothelioma patient who was exposed to asbestos while working as a welder, floor installer, and painter as well as during home renovations. The case was filed in Los Angeles, California in April of 2015 ...

Continue Reading...

Get Empowered

We put your medical and personal needs first and provide compassionate representation.

Speak with an Attorney